Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
CALL
iShares Gold Trust
IAU
$66.1B
| $1.46M | ﹤0.01% |
57,550
+50,850
| +759% | +$1.31M |
|
4077
Toro Company
TTC
$9.43B
| $1.46M | ﹤0.01% |
31,200
-62,600
| -67% | -$2.93M |
|
4078
PUT
Celldex Therapeutics
CLDX
$3.07B
| $1.46M | ﹤0.01% |
24,087
+9,494
| +65% | +$591K |
|
4079
PUT
IAMGOLD
IAG
$11.8B
| $1.46M | ﹤0.01% |
360,400
-68,800
| -16% | -$314K |
|
4080
PUT
Silicon Motion
SIMO
$8.33B
| $1.46M | ﹤0.01% |
+28,200
| New | +$1.47M |
|
4081
NetApp
NTAP
$36.7B
| $1.46M | ﹤0.01% |
40,620
+26,605
| +190% | +$811K |
|
4082
CALL
O-I Glass
OI
$1.14B
| $1.46M | ﹤0.01% |
79,100
-67,500
| -46% | -$1.22M |
|
4083
Rockwell Medical
RMTI
$32.9M
| $1.46M | ﹤0.01% |
1,974
-1,473
| -43% | -$1.19M |
|
4084
PUT
FreightCar America
RAIL
$235M
| $1.45M | ﹤0.01% |
101,100
+19,400
| +24% | +$277K |
|
4085
PUT
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| $1.45M | ﹤0.01% |
11,900
-22,500
| -65% | -$2.72M |
|
4086
Lennar Class B
LEN.B
$20.5B
| $1.45M | ﹤0.01% |
46,456
+15,469
| +50% | +$537K |
|
|
CTRL
4087
PUT
DELISTED
Control4 Corporation
CTRL
| $1.45M | ﹤0.01% |
118,300
+89,200
| +307% | +$913K |
|
|
BLOX
4088
PUT
DELISTED
Infoblox Inc
BLOX
| $1.45M | ﹤0.01% |
55,100
-3,700
| -6% | -$77.9K |
|
4089
PUT
NiSource
NI
$19.5B
| $1.45M | ﹤0.01% |
60,100
+20,900
| +53% | +$523K |
|
4090
CALL
NNN REIT
NNN
$8.77B
| $1.45M | ﹤0.01% |
28,500
+19,200
| +206% | +$981K |
|
4091
WisdomTree Japan SmallCap Dividend Fund
DFJ
$405M
| $1.45M | ﹤0.01% |
23,541
+889
| +4% | +$52.3K |
|
4092
CALL
Axos Financial
AX
$5.55B
| $1.45M | ﹤0.01% |
64,600
-4,800
| -7% | -$93.2K |
|
|
QUOT
4093
CALL
DELISTED
Quotient Technology Inc
QUOT
| $1.45M | ﹤0.01% |
108,700
-102,400
| -49% | -$1.36M |
|
4094
New Jersey Resources
NJR
$5.44B
| $1.45M | ﹤0.01% |
44,000
-41,140
| -48% | -$1.46M |
|
4095
CALL
Reinsurance Group of America
RGA
$16B
| $1.45M | ﹤0.01% |
13,400
-4,200
| -24% | -$429K |
|
4096
PUT
Rambus
RMBS
$9.3B
| $1.45M | ﹤0.01% |
115,700
+33,700
| +41% | +$445K |
|
4097
CALL
Western Alliance Bancorporation
WAL
$8.57B
| $1.45M | ﹤0.01% |
38,500
+8,500
| +28% | +$302K |
|
4098
AerCap
AER
$23.2B
| $1.44M | ﹤0.01% |
37,500
| – | – |
|
|
APU
4099
PUT
DELISTED
AmeriGas Partners, L.P.
APU
| $1.44M | ﹤0.01% |
31,600
-13,300
| -30% | -$621K |
|
4100
Ally Financial
ALLY
$12.8B
| $1.44M | ﹤0.01% |
74,077
-331,959
| -82% | -$6.17M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.